Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Herbert

Showing results (251-260 of 269) with videos related to

Pageof 27
Sort By:
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infectionAndrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Powassan Virus Seroprevalence in a U.S. Servicemember Population at High Risk for Tick ExposureAlexandra L Tse, Zoey Dipasqua, Joelle El Hamouche, et al.
Science Translational Medicine|March 16, 2022
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantavirusesEva Mittler, Anna Z Wec, Janne Tynell, et al.
Cell Host & Microbe|January 11, 2019
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus ProtectionAnna Z Wec, Zachary A Bornholdt, Shihua He, et al.
Cell|June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverJ Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Nature|November 23, 2018
Protocadherin-1 is essential for cell entry by New World hantavirusesRohit K Jangra, Andrew S Herbert, Rong Li, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Pageof 27

Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infectionAndrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Powassan Virus Seroprevalence in a U.S. Servicemember Population at High Risk for Tick ExposureAlexandra L Tse, Zoey Dipasqua, Joelle El Hamouche, et al.
Science Translational Medicine|March 16, 2022
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantavirusesEva Mittler, Anna Z Wec, Janne Tynell, et al.
Cell Host & Microbe|January 11, 2019
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus ProtectionAnna Z Wec, Zachary A Bornholdt, Shihua He, et al.
Cell|June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverJ Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Nature|November 23, 2018
Protocadherin-1 is essential for cell entry by New World hantavirusesRohit K Jangra, Andrew S Herbert, Rong Li, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Pageof 27